KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Total Liabilities (2016 - 2025)

Precigen (PGEN) has disclosed Total Liabilities for 15 consecutive years, with $134.6 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 71.38% to $134.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $134.6 million through Dec 2025, up 71.38% year-over-year, with the annual reading at $134.6 million for FY2025, 71.38% up from the prior year.
  • Total Liabilities for Q4 2025 was $134.6 million at Precigen, up from $129.4 million in the prior quarter.
  • The five-year high for Total Liabilities was $265.6 million in Q2 2022, with the low at $28.1 million in Q3 2024.
  • Average Total Liabilities over 5 years is $127.1 million, with a median of $110.6 million recorded in 2025.
  • The sharpest move saw Total Liabilities tumbled 84.44% in 2023, then surged 360.52% in 2025.
  • Over 5 years, Total Liabilities stood at $252.5 million in 2021, then tumbled by 64.47% to $89.7 million in 2022, then tumbled by 63.73% to $32.5 million in 2023, then surged by 141.31% to $78.5 million in 2024, then surged by 71.38% to $134.6 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $134.6 million, $129.4 million, and $107.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.